GB9801871D0 - Therapies - Google Patents

Therapies

Info

Publication number
GB9801871D0
GB9801871D0 GBGB9801871.6A GB9801871A GB9801871D0 GB 9801871 D0 GB9801871 D0 GB 9801871D0 GB 9801871 A GB9801871 A GB 9801871A GB 9801871 D0 GB9801871 D0 GB 9801871D0
Authority
GB
United Kingdom
Prior art keywords
therapies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9801871.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Bristol
Original Assignee
University of Bristol
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Bristol filed Critical University of Bristol
Priority to GBGB9801871.6A priority Critical patent/GB9801871D0/en
Publication of GB9801871D0 publication Critical patent/GB9801871D0/en
Priority to PCT/GB1999/000290 priority patent/WO1999038530A1/en
Priority to EP99902688A priority patent/EP1049489A1/en
Priority to AU22900/99A priority patent/AU2290099A/en
Priority to CA002318190A priority patent/CA2318190A1/en
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G01N33/505—Cells of the immune system involving T-cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55544—Bacterial toxins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2405/00—Assays, e.g. immunoassays or enzyme assays, involving lipids
    • G01N2405/08—Sphingolipids
    • G01N2405/10—Glycosphingolipids, e.g. cerebrosides, gangliosides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB9801871.6A 1998-01-28 1998-01-28 Therapies Ceased GB9801871D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GBGB9801871.6A GB9801871D0 (en) 1998-01-28 1998-01-28 Therapies
PCT/GB1999/000290 WO1999038530A1 (en) 1998-01-28 1999-01-28 Agent capable of modulating a glycosphingolipid-associated activity thus affecting an immune disorder
EP99902688A EP1049489A1 (en) 1998-01-28 1999-01-28 Agent capable of modulating a glycosphingolipid-associated activity thus affecting an immune disorder
AU22900/99A AU2290099A (en) 1998-01-28 1999-01-28 Agent capable of modulating a glycosphingolipid-associated activity thus affecting an immune disorder
CA002318190A CA2318190A1 (en) 1998-01-28 1999-01-28 Agent capable of modulating a glycosphingolipid-associated activity thus affecting an immune disorder

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9801871.6A GB9801871D0 (en) 1998-01-28 1998-01-28 Therapies

Publications (1)

Publication Number Publication Date
GB9801871D0 true GB9801871D0 (en) 1998-03-25

Family

ID=10826080

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9801871.6A Ceased GB9801871D0 (en) 1998-01-28 1998-01-28 Therapies

Country Status (5)

Country Link
EP (1) EP1049489A1 (en)
AU (1) AU2290099A (en)
CA (1) CA2318190A1 (en)
GB (1) GB9801871D0 (en)
WO (1) WO1999038530A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9513733D0 (en) * 1995-07-05 1995-09-06 Univ Bristol Therapeutic agents
CA2163716C (en) * 1995-11-24 2009-05-19 Clifford A. Lingwood Verotoxin pharmaceutical compositions and medical treatments therewith
US5801145A (en) * 1996-02-09 1998-09-01 Ontario Cancer Institute Method for selectively purging CD77+ cells from bone marrow
AU7348998A (en) * 1997-05-16 1998-12-08 Hospital For Sick Children, The Inhibition of angiogenesis by verotoxins

Also Published As

Publication number Publication date
AU2290099A (en) 1999-08-16
EP1049489A1 (en) 2000-11-08
WO1999038530A1 (en) 1999-08-05
CA2318190A1 (en) 1999-08-05

Similar Documents

Publication Publication Date Title
DE69909613D1 (en) Bicyclische hydroxamsäurederivate
DE69924108D1 (en) Offshore-bohrsystem
DE59912932D1 (en) Arylphenylsubstituierte cyclische ketoenole
DE59912303D1 (en) Arylphenylsubstituierte cyclische ketoenole
DE69918845D1 (en) Polyketonlösung
DE69913545D1 (en) Pyrimidonderivate
GB0116362D0 (en) Ammumition
GB9909064D0 (en) Therapies
DE69943409D1 (en) Fmcw-radar
EA199900308A3 (en) Swichgear
DE69904335D1 (en) Aminomethylcarbonsäurederivate
DE69835235D1 (en) Thermoplastische silikonelastomere
DE69914921D1 (en) Phenyl-xanthinderivate
DE59903023D1 (en) Perorale wirkstoff-suspension
DE59914151D1 (en) Arylalkanoylpyridazine
DE69908871D1 (en) Thermisch härtbare glasplatte
DE69934603D1 (en) Elektrophotographischer photoconduktor
DE69915628D1 (en) Ritonavir-polymorph
DE60042897D1 (en) Photovervielfacherröhre
DE69939823D1 (en) Endo-beta-n-acetylglukosaminidase
DE69938146D1 (en) Ptc-chip-thermistor
DE69904442D1 (en) Cyclohexandiol-derivate
DE69905001D1 (en) Koagulationsvorrichtung
DE69925859D1 (en) Cycloalkylsubstituierte aminomethylpyrrolidin-derivate
DE59904407D1 (en) Chromanderivate

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)